Chi Q, Yang Z, Xu K, Wang C, Liang H. DNA Nanostructure as an efficient drug delivery platform for immunotherapy. Front Pharmacol. 2019;10:1585.

Article  CAS  PubMed  Google Scholar 

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303–10.

Article  PubMed  PubMed Central  Google Scholar 

Shang J, Wang Q, Zhang H, et al. The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan. China Am J Med. 2021;134(1):e6–14.

CAS  PubMed  Google Scholar 

Cariou B, Wargny M, Boureau AS, et al. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative. Diabetologia. 2022;65(9):1436–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068-1077 e1063.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

American Diabetes Association Professional Practice C. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S46–59.

Article  Google Scholar 

Sendur SN, Oguz SH, Unluturk U. COVID-19 vaccination and thyroiditis. Best Pract Res Clin Endocrinol Metab. 2023;37(4):101759

Bahcecioglu AB, Karahan ZC, Aydogan BI, Kalkan IA, Azap A, Erdogan MF. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Invest. 2022;45(4):865–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yano M, Morioka T, Natsuki Y, et al. New-onset type 1 diabetes after COVID-19 mRNA vaccination. Intern Med. 2022;61(8):1197–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aydogan BI, Unluturk U, Cesur M. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine. 2022;78(1):42–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samuel SM, Varghese E, Triggle CR, Busselberg D. COVID-19 vaccines and hyperglycemia-is there a need for postvaccination surveillance? Vaccines (Basel). 2022;10(3):454.

Sasaki K, Morioka T, Okada N, et al. New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. J Diabetes Investig. 2022;13(7):1286–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakurai K, Narita D, Saito N, et al. Type 1 diabetes mellitus following COVID-19 RNA-based vaccine. J Diabetes Investig. 2022;13(7):1290–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang X, He B, Liu Z, Zhou Z, Li X. Fulminant type 1 diabetes after COVID-19 vaccination. Diabetes Metab. 2022;48(2): 101324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi T, Yakou F, Saburi M, et al. New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: a case report. Clin Case Rep. 2022;10(10): e6473.

Article  PubMed  PubMed Central  Google Scholar 

Lin R, Lin YW, Chen MH. Fulminant type 1 diabetes mellitus after SARS-CoV-2 vaccination: a case report. Vaccines (Basel). 2022;10(11):1905.

Bleve E, Venditti V, Lenzi A, Morano S, Filardi T. COVID-19 vaccine and autoimmune diabetes in adults: report of two cases. J Endocrinol Invest. 2022;45(6):1269–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125: 102738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sasaki H, Itoh A, Watanabe Y, et al. Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: a case report. J Diabetes Investig. 2022;13(6):1105–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bally K, Ji B, Soni L. COVID-19 vaccine-induced latent autoimmune diabetes in adults. Cureus. 2023;15(1): e33762.

PubMed  PubMed Central  Google Scholar 

Grani G, Lamartina L, Durante C, Filetti S, Cooper DS. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2018;6(6):500–14.

Article  PubMed  Google Scholar 

Ben Nasr M, D’Addio F, Montefusco L, et al. Indirect and direct effects of SARS-CoV-2 on human pancreatic islets. Diabetes. 2022;71(7):1579–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217: 108480.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanzy A, Madkhali M, Imam S, Jaume J. IDF21-0512 development of latent autoimmune diabetes of adults post SARS-COV-2 mRNA vaccination. Diabetes Res Clin Prac. 2022;186: 109369.

Article  Google Scholar 

Schinas G, Polyzou E, Dimakopoulou V, Tsoupra S, Gogos C, Akinosoglou K. Immune-mediated liver injury following COVID-19 vaccination. World J Virol. 2023;12(2):100–8.

Article  PubMed  PubMed Central  Google Scholar 

Sgamato C, Rocco A, Compare D, et al. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol. 2023;29(12):1838–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akkuzu G, Bes C, Ozgur DS, et al. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature. Eur Rev Med Pharmacol Sci. 2023;27(5):2143–51.

CAS  PubMed  Google Scholar 

Alqatari S, Ismail M, Hasan M, et al. Emergence of post COVID-19 vaccine autoimmune diseases: a single center study. Infect Drug Resist. 2023;16:1263–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chourasia P, Goyal L, Kansal D, et al. Risk of new-onset diabetes mellitus as a post-COVID-19 condition and possible mechanisms: a scoping review. J Clin Med. 2023;12(3):1159.

Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020;43(11):e170–1.

Article  CAS  PubMed  Google Scholar 

Kamrath C, Monkemoller K, Biester T, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020;324(8):801–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sathish T, Cao Y, Kapoor N. Newly diagnosed diabetes in COVID-19 patients. Prim Care Diabetes. 2021;15(1):194.

Article  PubMed  Google Scholar 

Kuchay MS, Reddy PK, Gagneja S, Mathew A, Mishra SK. Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19. Diabetes Metab Syndr. 2020;14(6):2039–41.

Article  PubMed  PubMed Central  Google Scholar 

Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11: 617089.

Article  CAS  PubMed  Google Scholar 

Wu CT, Lidsky PV, Xiao Y, et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 2021;33(8):1565-1576 e1565.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coate KC, Cha J, Shrestha S, et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in beta cells. Cell Metab. 2020;32(6):1028-1040 e1024.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muller JA, Gross R, Conzelmann C, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3(2):149–65.

Article  PubMed